"CHRISTUS MUGUERZA Hospital Del Parque, ofrecemos servicios médicos para toda la familia con un alto estándar de calidad con tecnología de vanguardia. Nuestros protocolos de seguridad cuentan con los más altos estándares de calidad, avalados por el Consejo de Salubridad General."

During the past decade, Hospital Christus Muguerza del Parque conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Christus Muguerza del Parque" #1 sponsor was "Pfizer" with 4 trials, followed by "Celgene" with 3 trials sponsored, "Ferring Pharmaceuticals" with 3 trials sponsored, "Shire" with 3 trials sponsored and "Merz Pharmaceuticals GmbH" with 3 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Christus Muguerza del Parque" #1 collaborator was "Amgen" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Christus Muguerza del Parque" are "Crohn Disease" (3 trials), "Prostate Cancer" (3 trials), "Osteoporosis" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Hospital Christus Muguerza del Parque" in a lesser frequency.

Most popular intervention types in "Hospital Christus Muguerza del Parque" are "Drug" (14 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ozanimod" (3 trials), "Degarelix" (2 trials), "Goserelin acetate" (2 trials) and "Tofacitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Christus Muguerza del Parque" are 10 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Christus Muguerza del Parque". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hospital Christus Muguerza del Parque, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Christus Muguerza del Parque, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".